Molecular genetic identification of families with juvenile nephronophthisis type 1: rate of progression to renal failure. APN Study Group. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Familial juvenile nephronophthisis (NPH), an autosomal recessive cystic disease of the kidney, is the most common genetic cause of end-stage renal disease (ESRD) in the first two decades of life. A gene locus for nephronophthisis type 1 (NPH1) has been mapped by linkage analysis to chromosome 2q13. We performed a haplotype analysis in 16 NPH families with at least two affected patients with the typical history, clinical signs and histology of NPH using microsatellite markers of the NPH1 genetic region. By demonstration of a recombinant event marker D2S1893 was identified as a novel centromeric flanking marker to the NPH1 critical genetic region. Absence of linkage to the NPH1 locus in six NPH families confirmed the existence of at least one additional gene locus for NPH. Linkage to the NPH1 locus was demonstrated in 10 families. In 8 of these families a homozygous deletion was identified. These data permit for the first time the study of the development of renal failure in a subset of NPH1 families, which is most likely homogeneous with regard to the responsible gene locus. We present a statistical description of serial serum creatinine measurements in NPH1. Analysis of renal death revealed a median of 13.1 years. Age-dependent quartiles were generated for serum creatinine. In summary, the new marker provides a diagnostic tool to aid in the diagnosis of NPH, while the progression charts offer a standard for an assessment of the rate of progression to ESRD for patients with NPH1 to be used in future therapeutic trials and for a prediction of the individual course of the disease.
Hildebrandt
F
F
University Children's Hospital, Freiburg University, Freiburg, Germany. hildebra@sun1.ukl.uni-freiburgh.de
Strahm
B
B
Nothwang
H G
HG
Gretz
N
N
Schnieders
B
B
Singh-Sawhney
I
I
Kutt
R
R
Vollmer
M
M
Brandis
M
M
D004276:DNA, Satellite / Q000032:analysis; D018450:Disease Progression; D005060:Europe; D005260:Female; D005819:Genetic Markers; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D052177:Kidney Diseases, Cystic / Q000235:genetics* / Q000401:mortality; D007676:Kidney Failure, Chronic / Q000235:genetics* / Q000401:mortality; D008297:Male; D010375:Pedigree; D016019:Survival Analysis
D004276:DNA, Satellite; D005819:Genetic Markers